SciLog Awards World-Wide Patent License To GE Healthcare
SciLog, Inc. located in Middleton, Wisconsin announced the signing of a Patent Licensing Agreement with GE Healthcare. This agreement provides GE Healthcare with a worldwide license for a manifold system that enables the company to manufacture and market automated single-use purification platforms for use in biopharmaceutical production. This innovative technology concept was developed by Karl G. Schick, Ph.D., co-founder and Chairman of SciLog, Inc. The technology is covered by multiple US and International Patents that have been granted and assigned to SciLog, Inc.
SciLog, Inc. is a privately held company that designs and manufactures computer-controlled bioprocessing equipment for use in biopharmaceutical laboratories and production facilities. Recently, SciLog introduced a family of disposable, pre-calibrated sensors for single-use purification platforms. GE Healthcare recently introduced ReadyToProcess™ plug and play platforms, which are easily scalable and add significant operational efficiency to biopharmaceutical processing. Ready to use processing and fluid handling platforms are used increasingly in biopharmaceutical processing of monoclonal antibodies, vaccines, proteins and other biologically derived materials. The solution to be processed is aseptically connected to the inlet of the pre-sanitized holding or purification platform. The purified product is collected aseptically at the outlet of the closed platform. The flow path of the platform is discarded once the final product has been collected.
"Significant cost reductions are achievable with single-use purification platforms" comments Juliette J. Schick, Ph.D., co-founder and CEO of SciLog Inc. "In addition, users are avoiding process contamination and lengthy process validation issues by utilizing pre-validated, single-use purification platforms." "Another advantage is the scalability of the single-use platform concept. Customers can readily purify small, liter-sized process volumes, as well as large, 1000+ liter production volumes by changing the size of the process bags and associated purification modules."
"We are obviously very delighted to be partnering with a world-class company such as GE Healthcare. We are looking forward to a long and prosperous relationship," commented Karl G. Schick, Chairman of SciLog, Inc.
SOURCE: SciLog, Inc.